Diabetes - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin deficiency or resistance leads to impaired glucose uptake by cells, causing elevated blood glucose levels. In type 1 diabetes, autoimmune destruction of pancreatic beta cells results in insufficient insulin production. In type 2 diabetes, insulin resistance in peripheral tissues is the main problem, often accompanied by inadequate insulin secretion.
• Secondary mechanism: Chronic hyperglycemia triggers inflammation and oxidative stress, damaging blood vessels and nerves. This contributes to the development of microvascular complications (e.g., retinopathy, nephropathy) and macrovascular complications (e.g., cardiovascular disease).
• Key complication: Persistent high blood glucose levels can lead to diabetic ketoacidosis in type 1 diabetes, a life-threatening condition characterized by the accumulation of ketones in the blood, resulting in acidosis and requiring urgent medical intervention.
Patient Profile
Demographics:
55-year-old male, construction worker
History:
• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia
• Current medications: Metformin 1000 mg BID, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing fatigue and intermittent blurred vision
• Key symptoms: Polyuria, polydipsia, peripheral neuropathy, occasional dizziness
• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, BMI 29.5
Section 1
Initial Assessment Findings:
During the initial assessment, the nurse notes that the patient's blood glucose level is significantly elevated at 260 mg/dL, despite adherence to his prescribed medication regimen. His glycated hemoglobin (HbA1c) level is 9.1%, indicating poor long-term glycemic control. Upon further questioning, the patient admits to inconsistently following dietary recommendations, often due to irregular meal times at work and frequent consumption of high-carbohydrate snacks for convenience. The physical examination reveals diminished sensation in the patient's feet, confirmed by monofilament testing, suggesting progression of peripheral neuropathy. Fundoscopic examination shows early signs of diabetic retinopathy, with microaneurysms and slight retinal hemorrhages visible.
These findings highlight the need for a comprehensive reassessment of the patient's diabetes management plan. The healthcare team discusses the importance of tighter glycemic control to prevent further complications, emphasizing lifestyle modifications such as dietary adjustments and regular physical activity. Additionally, the need for potential medication adjustments is considered, possibly including the initiation of an additional oral hypoglycemic agent or insulin therapy to achieve better control over his blood glucose levels. The patient's blood pressure, though slightly elevated, is controlled well by his current antihypertensive regimen, but continued monitoring is advised given the risk of cardiovascular complications associated with diabetes and hypertension. This scenario requires the nurse to prioritize patient education and collaborate with the multidisciplinary team to tailor an individualized care plan, addressing both the current symptoms and the prevention of future complications.
Section 2
As the healthcare team revisits the patient's management plan, they decide to initiate a new diagnostic workup to evaluate the progression of his diabetes and associated complications. Laboratory tests reveal an increase in urinary microalbumin levels, suggesting early diabetic nephropathy. This finding is concerning, as it indicates the beginning of kidney damage, a common complication in poorly controlled diabetes. The patient's serum creatinine level is slightly elevated at 1.4 mg/dL, signaling a need for more aggressive management strategies to preserve renal function. Additionally, a lipid panel shows elevated LDL cholesterol at 130 mg/dL, which, combined with the patient's existing hypertension, increases his cardiovascular risk profile.
In light of these new diagnostic results, the healthcare team emphasizes the urgency of implementing lifestyle modifications and possibly adjusting the patient's pharmacological regimen. A referral to a dietitian is made to assist the patient in developing a meal plan that accommodates his work schedule while maintaining lower carbohydrate intake. The addition of an ACE inhibitor is considered to protect renal function by reducing proteinuria, despite the patient's current adequate blood pressure control. Furthermore, a discussion regarding the initiation of a statin is initiated to address hyperlipidemia and lower the risk of cardiovascular events.
The patient is informed about the significance of these findings and the potential implications for his health if not managed effectively. The nurse takes an active role in educating the patient about the importance of regular follow-up appointments, adherence to medication, and lifestyle changes to prevent the progression of complications. This collaborative and proactive approach aims to empower the patient, reduce anxiety, and improve adherence to the revised care plan, setting the stage for reassessment and potential adjustments in future consultations.
Section 3
Change in Patient Status:
Over the subsequent weeks, the patient diligently adheres to the new management plan, attending regular appointments and following the dietary recommendations provided by the dietitian. However, during a routine follow-up, the nurse notes a slight increase in the patient's blood pressure, now measuring at 145/90 mmHg, which is slightly above his previous readings. This change prompts concern, as it could potentially exacerbate renal issues and cardiovascular risk despite the recent introduction of an ACE inhibitor. The healthcare team decides to conduct a thorough assessment to identify any contributing factors, such as medication adherence, dietary intake, and stress levels, which might be influencing this change in blood pressure.
Additionally, the patient reports experiencing occasional episodes of dizziness and fatigue, which are new symptoms for him. Upon further questioning, the nurse discovers that these symptoms tend to occur in the late afternoon, suggesting a possible link to blood glucose fluctuations throughout the day. A point-of-care blood glucose test reveals levels at 72 mg/dL during one of these episodes, indicating hypoglycemia. This finding suggests a need to reassess his current insulin regimen or meal timing to prevent further episodes. The nurse collaborates with the healthcare team to plan adjustments to his insulin dosing schedule, ensuring better alignment with his activity level and meal times, while reinforcing the importance of monitoring glucose levels regularly.
The healthcare team decides to initiate closer monitoring of the patient's renal function and blood pressure, with follow-up appointments scheduled more frequently to ensure that any adjustments are effective. The patient is educated on recognizing signs of hypoglycemia, such as dizziness and fatigue, and is encouraged to keep a log of his blood pressure and blood glucose levels to facilitate ongoing evaluation. This proactive approach aims to address the new challenges in his management plan, with the goal of stabilizing his condition and preventing further complications.
Section 4
As the patient's management plan evolves, the healthcare team focuses on the initial assessment findings from the recent follow-up to guide their next steps. During the assessment, the nurse notes that the patient has gained approximately 2 kg over the last month, despite adhering to dietary guidelines. This weight gain, coupled with elevated blood pressure and episodes of dizziness, leads the team to suspect fluid retention, possibly linked to the renal complications of diabetes. A thorough physical examination reveals mild peripheral edema, more pronounced in the patient's ankles, which was not present in previous visits. These findings prompt the team to prioritize a closer evaluation of the patient’s renal function and potential fluid overload.
The laboratory results further elucidate the situation: the patient's serum creatinine level has risen from 1.2 mg/dL to 1.5 mg/dL, and the estimated glomerular filtration rate (eGFR) has decreased to 55 mL/min/1.73m², indicating a decline in kidney function. Additionally, a spot urine test reveals microalbuminuria, confirming early nephropathy. These diagnostic results underscore the need for an integrated approach to manage both the patient’s cardiovascular and renal risks. The team discusses the need for potential adjustments in the patient’s medication regimen, considering the use of diuretics to address fluid retention while carefully monitoring electrolytes to avoid exacerbating hypoglycemic episodes.
Faced with these developments, the healthcare team collaborates to formulate a revised care plan. They decide to adjust the patient’s ACE inhibitor dosage and introduce a low-dose diuretic to manage blood pressure and fluid balance, aiming to mitigate further renal damage. The patient is educated about the importance of adhering to fluid and salt restrictions and is instructed to continue monitoring his blood pressure and glucose levels closely. The team emphasizes the significance of immediate reporting of any worsening symptoms such as increased fatigue or swelling, as these could indicate further complications. This proactive strategy aims to stabilize the patient's condition while addressing the multifaceted challenges posed by diabetes and its evolving complications.
Section 5
Following the implementation of the revised care plan, the healthcare team closely monitors the patient’s response to interventions over the next few weeks. Initially, the patient reports a slight improvement in symptoms, with the peripheral edema reducing and blood pressure readings showing a modest decline. However, during a routine follow-up visit, the nurse notes a new complication: the patient has developed mild persistent cough and occasional shortness of breath. The patient's blood pressure is now averaging 138/86 mmHg, and a new weight measurement reveals an additional 1 kg gain since the last visit, despite adherence to dietary and medication guidelines.
These developments prompt further investigation into potential causes. A chest X-ray is ordered to rule out pulmonary congestion, and the team considers the possibility of the cough being a side effect of the increased ACE inhibitor dosage. Meanwhile, laboratory tests reveal a slight decrease in serum potassium levels to 3.4 mEq/L, raising concerns about electrolyte imbalance secondary to the diuretic therapy. The patient's serum creatinine remains at 1.5 mg/dL, but the eGFR has slightly improved to 58 mL/min/1.73m², suggesting some stabilization of renal function.
Faced with these new findings, the healthcare team engages in clinical reasoning to adjust the patient's care plan further. They decide to switch the patient from an ACE inhibitor to an angiotensin receptor blocker (ARB) to manage blood pressure while minimizing the risk of persistent cough. Additionally, the diuretic dosage is reassessed, and potassium supplements are introduced to address the hypokalemia. The team re-emphasizes the importance of daily weight monitoring and symptom tracking, instructing the patient to report any new or worsening symptoms promptly. This approach aims to refine the management strategy, balancing the need to address cardiovascular and renal risks while minimizing medication-related side effects.